Rennova Health, Inc.

Total Valuation

Rennova Health, Inc. carries a market capitalization of 4.31M, placing it among publicly traded companies globally. Its enterprise value stands at 14.75M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Rennova Health, Inc. currently has 40.55B shares outstanding.

Valuation Ratios

Rennova Health, Inc. trades at a trailing price-to-earnings ratio of 0.98. The price-to-sales ratio is 0.16, and the price-to-book ratio stands at 0.00.

Enterprise Valuation

On an enterprise value basis, Rennova Health, Inc. trades at an EV/EBITDA multiple of 8.80 and an EV/FCF ratio of 2.37. The EV/Sales ratio of 0.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.80 provides insight into valuation relative to core operating earnings.

Financial Position

Rennova Health, Inc. maintains a current ratio of 0.16, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -31.96, indicating conservative leverage, while an interest coverage ratio of 1.15 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Rennova Health, Inc. has paid 239,834.00 in income taxes, reflecting an effective tax rate of 28.70.

Stock Price Statistics

Rennova Health, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Income Statement

Over the trailing twelve months, Rennova Health, Inc. generated 18.69M in revenue and converted that into -7.73M in net income, yielding earnings per share of 0.00. EBITDA reached 1.68M, while operating income came in at 1.37M.

Balance Sheet

Rennova Health, Inc. holds 49,015.00 in cash and equivalents against 11.78M in total debt, resulting in a net debt position of 11.37M. Total book value stands at -1.71B, with working capital of -35.56M providing operational flexibility.

Cash Flow

Rennova Health, Inc. produced 3.39M in operating cash flow over the past twelve months. After subtracting -276,983.00 in capital expenditures, free cash flow totaled 3.11M - equivalent to 0.00 per share.

Margins

Rennova Health, Inc. operates with a gross margin of 59.46, reflecting its pricing power and cost economics. The operating margin of 7.31 and net profit margin of -41.36 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Rennova Health, Inc.'s most recent stock split took place on March 16, 2022 with a 10000:1 split ratio.

Scores

Rennova Health, Inc. posts an Altman Z-Score of -120.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.